Navigation Links
CLAAD Petitions FDA To Reject Opioid Medications Without Safety Features
Date:6/11/2013

WASHINGTON, June 11, 2013 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) joined in signing a Citizen Petition filed today urging the Food and Drug Administration (FDA) to fully implement the Obama administration's policy supporting a market transition to safer opioid medications. The petition asks that the FDA reject applications for new opioid medications without added safety features.

Opioids are a class of synthetically derived chemicals often used to treat pain or addiction. Opioid analgesics were involved in over 16,000 overdose deaths in 2010 alone, according to the Centers for Disease Control.

The petition praises the FDA's recent steps to shift the market to safer medications, such as the April conclusion that the original OxyContin pill was removed from the market for safety reasons. Copies of the non-abuse-deterrent formulation will not be approved because of this decision.

Recent FDA decisions regarding generic opioids cloud the future of abuse-deterrent medications. In May, the FDA ruled that manufacturers will be allowed to bring to market as early as July 1 more generic forms of a non-abuse deterrent version of Opana ER. The FDA is also expected to decide soon whether to approve an application for a new, pure hydrocodone pill with no abuse-deterrent features.

CLAAD's executive director, Michael Barnes, explained the need for action: "The availability of more generic, non-abuse-deterrent opioids increases the supply of drugs that people are eager and able to abuse. The better approach is to replace that supply with abuse-deterrent medications."

The citizen petition is asking that the FDA act speedily in accordance with the urgency of the national prescription abuse epidemic. By law, the FDA has 180 days to reply.

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) coordinates a comprehensive national effort to prevent the prescription drug fraud, diversion, misuse, and abuse while advancing patient access to high-quality medical care. CLAAD enables health professionals, law enforcement, businesses, and government, and others, to share resources and work together to improve public health and safety.  Follow @claad_coalition.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
5. CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
6. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
7. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
8. TRICAST Debuts Part D Rejection Oversight Solution for Drug Plan Sponsors
9. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
10. Express Scripts Recommends Rejection of TRC Capitals "Mini-Tender" Offer
11. New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
Breaking Medicine News(10 mins):